SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001567892-24-000029
Filing Date
2024-08-06
Accepted
2024-08-06 06:45:06
Documents
15
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnk-20240806.htm   iXBRL 8-K 25944
2 EX-99.1 mnkexhibit991q22024.htm EX-99.1 548143
6 GRAPHIC mallinckrodtlogoa11a.jpg GRAPHIC 18959
  Complete submission text file 0001567892-24-000029.txt   764455

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20240806.xsd EX-101.SCH 2283
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20240806_lab.xml EX-101.LAB 22462
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20240806_pre.xml EX-101.PRE 13154
17 EXTRACTED XBRL INSTANCE DOCUMENT mnk-20240806_htm.xml XML 2709
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 241176984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)